Clearmind Medicine Common Stock Current Valuation
| CMND Stock | USD 1.13 0.04 3.67% |
Valuation analysis of Clearmind Medicine Common helps investors to measure Clearmind Medicine's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Clearmind Medicine's price fluctuation is extremely dangerous at this time. Calculation of the real value of Clearmind Medicine Common is based on 3 months time horizon. Increasing Clearmind Medicine's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Clearmind stock is determined by what a typical buyer is willing to pay for full or partial control of Clearmind Medicine Common. Since Clearmind Medicine is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clearmind Stock. However, Clearmind Medicine's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.13 | Real 1.26 | Hype 1.13 |
The real value of Clearmind Stock, also known as its intrinsic value, is the underlying worth of Clearmind Medicine Common Company, which is reflected in its stock price. It is based on Clearmind Medicine's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Clearmind Medicine's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Clearmind Medicine Common helps investors to forecast how Clearmind stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clearmind Medicine more accurately as focusing exclusively on Clearmind Medicine's fundamentals will not take into account other important factors: Clearmind Medicine Common Company Current Valuation Analysis
Clearmind Medicine's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Clearmind Medicine Current Valuation | (1.69 M) |
Most of Clearmind Medicine's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Clearmind Medicine Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Clearmind Medicine Common has a Current Valuation of (1.69 Million). This is 100.01% lower than that of the Biotechnology sector and 100.04% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.01% higher than that of the company.
Clearmind Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Clearmind Medicine's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Clearmind Medicine could also be used in its relative valuation, which is a method of valuing Clearmind Medicine by comparing valuation metrics of similar companies.Clearmind Medicine is currently under evaluation in current valuation category among its peers.
Clearmind Fundamentals
| Return On Equity | -2.57 | ||||
| Return On Asset | -0.54 | ||||
| Current Valuation | (1.69 M) | ||||
| Shares Outstanding | 4.69 M | ||||
| Shares Owned By Insiders | 3.43 % | ||||
| Shares Owned By Institutions | 13.98 % | ||||
| Number Of Shares Shorted | 274.61 K | ||||
| Price To Earning | (750.00) X | ||||
| Price To Book | 1.65 X | ||||
| EBITDA | (5.85 M) | ||||
| Net Income | (5.25 M) | ||||
| Cash And Equivalents | 1.65 K | ||||
| Total Debt | 53.14 K | ||||
| Current Ratio | 0.03 X | ||||
| Book Value Per Share | 0.73 X | ||||
| Cash Flow From Operations | (4.86 M) | ||||
| Short Ratio | 3.19 X | ||||
| Earnings Per Share | (1.69) X | ||||
| Beta | -1.46 | ||||
| Market Capitalization | 5.3 M | ||||
| Total Asset | 7.26 M | ||||
| Retained Earnings | (24.02 M) | ||||
| Working Capital | 2.96 M | ||||
| Net Asset | 7.26 M |
About Clearmind Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Clearmind Medicine Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Clearmind Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Clearmind Medicine Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Clearmind Medicine Common is a strong investment it is important to analyze Clearmind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clearmind Medicine's future performance. For an informed investment choice regarding Clearmind Stock, refer to the following important reports:Check out Clearmind Medicine Piotroski F Score and Clearmind Medicine Altman Z Score analysis. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clearmind Medicine. If investors know Clearmind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clearmind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Clearmind Medicine Common is measured differently than its book value, which is the value of Clearmind that is recorded on the company's balance sheet. Investors also form their own opinion of Clearmind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Clearmind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clearmind Medicine's market value can be influenced by many factors that don't directly affect Clearmind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clearmind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clearmind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clearmind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.